MZF1 and neuroblastoma: Log‐rank test of 88 (GSE16476) and 498 (GSE62564)12 NB cases indicated that patients with high MZF1 expression had poorer survival (P = 2.0 × 10−2 and P = 9.6 × 10−3; Figure 1C).